Tag Archives: Could

Could a New Drug Help Ease Alzheimer’s?

SATURDAY, March 13, 2021 — About 7 out of 10 Alzheimer’s patients wound up free of the brain plaques that are a hallmark of the disease after treatment with a potentially breakthrough experimental drug, clinical trial results show. The drug, donanemab, also significantly slowed the patients’ brain decline, according to findings published March 13 in… Read More »